Cargando…

DNA methylation-regulated YTHDF2 correlates with cell migration and immune cell infiltration in glioma

Background: Glioma is a lethal malignant brain tumor, it comprises about 80% of all malignant brain tumours. Mounting evidence has reported that YTHDF2 plays a significant role in the cancer progression. However, the effects of YTHDF2 on the prognosis of low-grade gliomas (LGGs) and its correlation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Xiulin, Chen, Xi, Huang, Xiaobin, Wang, Chunyan, Wang, Chenyang, Pan, Chenglong, Cho, William C., Nie, Zhi, Pu, Jun, Wang, Weixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596213/ https://www.ncbi.nlm.nih.gov/pubmed/35661004 http://dx.doi.org/10.18632/aging.204104

Ejemplares similares

DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progression
por: Chen, Xi, et al.
Publicado: (2022)

Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma
por: Xiulin, Jiang, et al.
Publicado: (2022)

Long Non-Coding RNA AP000695.2 Acts as a Novel Prognostic Biomarker and Regulates the Cell Growth and Migration of Lung Adenocarcinoma
por: Wang, Chunyan, et al.
Publicado: (2022)

The N6-Methylandenosine-Related Gene BIRC5 as a Prognostic Biomarker Correlated With Cell Migration and Immune Cell Infiltrates in Low Grade Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

YTHDF2 correlates with tumor immune infiltrates in lower-grade glioma
por: Lin, Xiangan, et al.
Publicado: (2020)

Prognostic values of YTHDF1 regulated negatively by mir‐3436 in Glioma
por: Xu, Chenyang, et al.
Publicado: (2020)

DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma
por: Zhou, Fang, et al.
Publicado: (2023)

Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinoma
por: Koh, Young Wha, et al.
Publicado: (2022)

Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis
por: Nie, Zhi, et al.
Publicado: (2022)

Research progress of Bub3 gene in malignant tumors
por: Wang, Chenyang, et al.
Publicado: (2022)

KRT17 Promotes T-lymphocyte Infiltration Through the YTHDF2–CXCL10 Axis in Colorectal Cancer
por: Liang, Wenfeng, et al.
Publicado: (2023)

The function and clinical implication of YTHDF1 in the human system development and cancer
por: Ren, Wenjun, et al.
Publicado: (2023)

Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma
por: Liu, Xu-Sheng, et al.
Publicado: (2022)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Su, Ganglin, et al.
Publicado: (2021)

m(6)A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner
por: Wu, Ruifan, et al.
Publicado: (2019)

YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44
por: Li, Weijian, et al.
Publicado: (2021)

YTHDF1-enhanced iron metabolism depends on TFRC m(6)A methylation
por: Ye, Jing, et al.
Publicado: (2020)

YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration
por: Zhang, Yihan, et al.
Publicado: (2023)

Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression
por: Tang, Feng, et al.
Publicado: (2022)

The N6-Methyladenosine (m6A) Methylation Gene YTHDF1 Reveals a Potential Diagnostic Role for Gastric Cancer
por: Liu, Tong, et al.
Publicado: (2020)

Diagnostic value and immune infiltration characterization of YTHDF2 as a critical m6A regulator in osteoarthritic synovitis
por: Bian, Ashuai, et al.
Publicado: (2023)

YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m(6)A
por: Hong, Ling, et al.
Publicado: (2021)

YTHDF1 promotes mRNA degradation via YTHDF1‐AGO2 interaction and phase separation
por: Li, Jiong, et al.
Publicado: (2021)

YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer
por: Tsuchiya, Kazuo, et al.
Publicado: (2021)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells
por: Li, Jie, et al.
Publicado: (2020)

Research progress on the relationship between m(6)A methylation of YTHDF1 gene in the striatum and stereotyped behavior
por: Wen, Xiaohan, et al.
Publicado: (2022)

The m(6)A “reader” YTHDF1 promotes osteogenesis of bone marrow mesenchymal stem cells through translational control of ZNF839
por: Liu, Tao, et al.
Publicado: (2021)

Integrated Clinical and Prognostic Analysis of the m(6)A RNA Methylation Regulator YTHDF3 in Pan-Cancer and its Correlation with Cancer Cell Proliferation
por: Cao, Leiqun, et al.
Publicado: (2022)

YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance
por: Sun, Yu, et al.
Publicado: (2022)

N(6)-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m(6)A/cyclin D1 in asthma
por: Wang, Juan, et al.
Publicado: (2023)

YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators
por: Fei, Qili, et al.
Publicado: (2020)

YTHDF3 as a new player in hematopoietic stem cell regulation
por: Mao, Xinjian, et al.
Publicado: (2022)

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study
por: Li, Xinyan, et al.
Publicado: (2022)

m(6)A binding protein YTHDF2 in cancer
por: Chen, Xiaomin, et al.
Publicado: (2022)

Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing’s sarcoma
por: Jiang, Jie, et al.
Publicado: (2022)

m(6)A RNA Methylation Regulator YTHDF1 Correlated With Immune Microenvironment Predicts Clinical Outcomes and Therapeutic Efficacy in Breast Cancer
por: Hu, Ying, et al.
Publicado: (2021)

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
por: Zheng, Guangrong, et al.
Publicado: (2022)

Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1
por: Yarmishyn, Aliaksandr A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gn8qrsn2a0tcdpat23lcq5bqb5